Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
复制标题
DOI:
10.1016/j.bbrc.2005.10.083
复制
发表时间:
2005-12
影响因子:
3.1
通讯作者:
K. Obata;K. Nagata;M. Iwase;M. Odashima;T. Nagasaka;H. Izawa;T. Murohara;Yoshiji Yamada;M. Yokota
中科院分区:
文献类型:
--
作者:
K. Obata;K. Nagata;M. Iwase;M. Odashima;T. Nagasaka;H. Izawa;T. Murohara;Yoshiji Yamada;M. Yokota
The possible role of calcineurin in cardiac hypertrophy induced by calmodulin (CaM) overexpression in the heart was investigated. CaM transgenic (CaM-TG) mice developed marked cardiac hypertrophy and exhibited up-regulation of atrial natriuretic factor (ANF) and β-myosin heavy chain gene expression in the heart during the first 2 weeks after birth. The activity of calcineurin in the heart was also significantly increased in CaM-TG mice compared with wild-type littermates. Treatment of CaM-TG mice with the calcineurin inhibitor FK506 (1mg/kg per day) prevented the increase in the heart-to-body weight ratio as well as that in cardiomyocyte width. FK506 also inhibited the induction of fetal-type cardiac gene expression in CaM-TG mice. Overexpression of CaM in cultured rat cardiomyocytes activated the ANF gene promoter in a manner sensitive to FK506. Activation of a calcineurin-dependent pathway thus contributes to the development of cardiac hypertrophy induced by CaM overexpression in the heart.